Search results for: Market Access
Filter search results
Our Certain Fate: Rationing in Health Care
1 November 1998
…to be rationed, that is unavoidable and ubiquitous, but how: what principles should determine patient access to health care and how should they be applied? This harsh reality can be…
Public Private Partnerships for Research and Development: Medicines and Vaccines for Diseases of Poverty
1 December 2002
Improving the health and life expectancy of the populations of the less developed countries of the world requires both better access to medicines and research and development (R&D) of new…
Opportunity Costs of Implementing NICE Decisions in NHS Wales
1 June 2014
This new research from the OHE examines how Local Health Boards (LHBs) in Wales adjust spending to meet the statutory requirement of providing access to technologies recommended by NICE within…
Data Governance Arrangements for Real-World Evidence: South Korea
1 September 2017
In 2015, OHE published a report which set out the core principles that should govern how Real-World Data (RWD) is accessed or generated, and used credibly to generate Real-World Evidence…
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy
1 March 2019
Where evidence is lacking for new treatments, because of practical or methodological difficulties, there is a risk that patients remain unable to access cost-effective care. We identify a variety of…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment
1 April 2019
…using value assessment analyses to support their purchasing decisions. Secondly, the Report lacks proposals to enable differential pricing and managed entry agreements to happen. Both can increase access while setting…
Indication-Based Pricing (IBP) Discussion Paper: Should drug prices differ by indication?
1 May 2019
…your views. To submit your thoughts, please access the survey which accompanies the Discussion Paper or use the following link: https://www.surveymonkey.co.uk/r/IBP_Consultation Consultation closing date: Monday, 30 September 2019. Increasingly, scientific…
Caring about Carers: Improving Consideration of the Burden of Informal Caring in HTA
11 April 2023
…can lead to substantively different results and recommendations that could undermine access to new technologies that could improve patient and carer outcomes. To address these challenges, and appropriately value the…
Real-World Evidence: Current Best Practice for Reimbursement Decision-Making
15 May 2023
…assessment and use of quality RWE in reimbursement decisions. Key takeaways Real-world evidence (RWE) can enable better-informed patient access decisions, but it is underutilised in reimbursement decisions This report reviews…